Financhill
Back

ImmunityBio Stock Predictions

ImmunityBio Stock Forecast

  • Is ImmunityBio Stock Undervalued?
    The current ImmunityBio [IBRX] share price is $2.81. The Score for IBRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • IBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will ImmunityBio Stock Go Up Next Year?

Data Unavailable

ImmunityBio Stock Rating

Data Unavailable

ImmunityBio Stock Price History

Is IBRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunitybio.com

52-Week Data

52-Week High:
10.53
52-Week Low:
2.50

Prediction Charts

Market Cap:
2B
Price in USD:
2.81
Volume:
4.8M
Beta:
1.38

Technical Analysis

SMA50:
4.31
SMA100:
4.01
SMA200:
5.13
52-Wk Change:
-40.53%

Stock Predictions

  • Is ImmunityBio stock public?
    Yes, ImmunityBio is a publicly traded company.
  • What is the ImmunityBio stock quote today?
    The ImmunityBio stock price is 2.81 USD today.
  • How to buy ImmunityBio stock online?
    You can buy ImmunityBio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 3.08 2.87 3.13 2.82
Dec-16 2.91 3.06 3.18 2.85
Dec-17 3.00 2.83 3.03 2.82
Dec-18 2.81 2.65 2.85 2.61
Dec-19 2.75 2.67 2.75 2.65
Dec-20 2.66 2.62 2.71 2.61
Dec-23 2.62 2.67 2.69 2.50
Dec-24 2.70 2.63 2.75 2.60
Dec-26 2.58 2.69 2.76 2.55
Dec-27 2.69 2.78 2.86 2.63
Dec-30 2.75 2.68 2.76 2.58
Dec-31 2.71 2.56 2.77 2.51
Jan-2 2.58 2.57 2.67 2.54
Jan-3 2.60 2.81 2.81 2.59

ImmunityBio Earnings

Data Unavailable

ImmunityBio Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.27 per share.

* ImmunityBio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.